Testosterone Benefits

Aging, Testosterone

Testosterone Replacement Therapy Benefits: Testosterone Benefits

Testosterone Benefits

Testosterone replacement therapy (TRT) in men with low testosterone has consistently shown to produce positive benefits with minimal side effects. Testosterone benefits include decreases in fat mass, increases in lean body mass, and increases in bone mineral density. Learn more about these specific positive benefits below.

While significant positive benefits are associated with TRT, certain effects have not been conclusively established. While TRT is usually well tolerated as long as testosterone is kept within normal, physiologic levels, side effects can occur. It is important for you and your physician to be aware of the following potential side effects. (See Testosterone Side Effects)

 

Testosterone Benefits: Testosterone Replacement Therapy and Lean Body Mass

Testosterone replacement therapy produces a moderate increase in lean body mass (muscle mass) in men with low testosterone associated with aging.1-9

Why’s That Important?

Lean Body Mass TestosteroneAs a man ages, he loses muscle mass, typically about 0.5- 1.0% per year after the age of 40. This loss becomes progressively faster after the age of 40 and is even worse if he has low testosterone associated with aging.10 Muscle mass contributes a great deal to resting metabolism.

Lean Body Mass Resting MetabolismThe increase in muscle mass brought about by testosterone replacement therapy can be highly beneficial, as it increases your lean body mass and thus raises your metabolism. The higher your resting metabolism, the more calories you burn at rest and the less likely you will be to put on excess fat. Don’t worry about becoming muscle bound. TRT users typically gain between three and six pounds of lean muscle mass in the first six months of treatment.1-7 Once testosterone levels are stabilized within normal range, increases in muscle mass typically taper off. This usually occurs after about 6 months of treatment. So, you will have more muscle mass but not too much more muscle.

Expanded Detailed Explanation

In trials of TRT for elderly men, its effects on body composition (muscle mass and fat mass) and strength have been the most extensively studied area. Studies show that testosterone administered to men with low testosterone levels has a tendency to increase lean body mass.1-9 These results occur over a wide array of administration methods, including transdermal creams,3 scrotal patches,4 oral pills,5and intramuscular injections.1,2,6,7 This result is not surprising considering exogenous androgen administration has myotrophic (muscle building) effects, including protein synthesis, increasing muscle fiber cross-sectional area, and reducing muscle degradation.6

 

Testosterone Benefits: Testosterone Replacement Therapy (TRT) and Fat Mass

Testosterone Replacement Therapy (TRT) Fat Mass

Testosterone replacement therapy (TRT) produces a moderate decrease in fat mass in elderly men with low testosterone associated with aging.1,3-7,11-14 Typical fat loses range between 5-10 pounds in the first 6 months of treatment.

Why’s That Important?

As men age, they typically gains fat mass, especially abdominal (AKA visceral) fat. Besides giving you an undesirable gut, this increase in visceral fat ultimately increases the incidence of cardiovascular problems, potentially leading to reduced quality of life and life expectancy. Testosterone therapy for men with low testosterone can keep you thinner and healthier since long-term studies consistently show a decrease in fat mass.

Testosterone Fat Mass

Expanded Detailed Explanation

In trials on TRT for elderly men, the effects on body composition and strength have been the most extensively studied area. Studies indicate that testosterone administration in men with low testosterone consistently decreases fat mass with rare exceptions. 1,3-7,11-15 A large number of studies have documented that visceral obesity is associated with low total testosterone levels.16-19 Returning testosterone to normal physiological levels with TRT may reverse this fat deposition while simultaneously increasing muscle mass.

 

Testosterone Benefits: Testosterone Replacement Therapy (TRT) and Bone Mineral Density

Testosterone Replacement Therapy (TRT) Bone Mineral DensityEvidence shows that testosterone replacement therapy may slow or even reverse the loss of bone mineral density due to decreased testosterone levels associated with aging.4,21-24

Why is Bone Mineral Density Important?

As men, we are not keen on admitting our weaknesses. Whether or not we want to admit it, osteoporosis and consequent fractures are NOT just a women’s health problem. This problem belongs to men just as it does to women. Hip fractures are not uncommon for men over the age of 65.22,23 Not only will a hip fracture or a fracture of another bone cause you to lose your functional independence, but it will also significantly increase your likelihood of death, particularly within one year of the fracture.7

Bone mineral graphic
Expanded Detailed Explanation

Many studies show that testosterone replacement therapy in men with low testosterone prevents bone loss.4,21-24 These studies showed an increase in bone mineral density at the lumbar spine compared to placebo controlled groups. One study reported no change in bone mineral density in the group receiving testosterone replacement therapy but a small significant decline in bone mineral density in the placebo group.3 Thus, testosterone replacement resulted in an overall positive treatment. It also shows that, while testosterone replacement therapy may not increase bone mineral density, it may prevent decreases in bone mineral density.

The effect of testosterone replacement therapy on fracture rates is unknown because data is not available. Nevertheless, testosterone replacement therapy clearly provides a positive effect on bone mineral density in men with significantly reduced testosterone levels and men under chronic treatment with glucocorticoids.

External Resources:

1. Page ST, Amory JK, Bowman FD, et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab. Mar 2005; 90 (3): 1502-1510.
2. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. Oct 1992; 75 (4): 1092-1098.
3. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci. May 2001; 56 (5): M266-272.
4. Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab. Jun 1999; 84 (6): 1966-1972.
5. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci. Jul 2003; 58 (7): 618-625.
6. Ferrando AA, Sheffield-Moore M, Yeckel CW, et al. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab. Mar 2002; 282 (3): E601-607.
7. Blackman MR, Sorkin JD, Münzer T, et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA. Nov 2002; 288 (18): 2282-2292.
8. Frontera WR, Hughes VA, Fielding RA, Fiatarone MA, Evans WJ, Roubenoff R. Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol. Apr 2000; 88 (4): 1321-1326.
9. Sinha-Hikim I, Cornford M, Gaytan H, Lee ML, Bhasin S. Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab. Aug 2006; 91 (8): 3024-3033.
10. Lambert CP, Evans WJ. Adaptations to aerobic and resistance exercise in the elderly. Rev Endocr Metab Disord. May 2005; 6 (2): 137-143.
11. Rebuffé-Scrive M, Mårin P, Björntorp P. Effect of testosterone on abdominal adipose tissue in men. Int J Obes. Nov 1991; 15 (11): 791-795.
12. Rolf C, von Eckardstein S, Koken U, Nieschlag E. Testosterone substitution of hypogonadal men prevents the age-dependent increases in body mass index, body fat and leptin seen in healthy ageing men: results of a cross-sectional study. Eur J Endocrinol. Apr 2002; 146 (4): 505-511.
13. Mårin P, Arver S. Androgens and abdominal obesity. Baillieres Clin Endocrinol Metab. Oct 1998; 12 (3): 441-451.
14. Mårin P, Odén B, Björntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab. Jan 1995; 80 (1): 239-243.
15. Sih R, Morley JE, Kaiser FE, Perry HM, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab. Jun 1997; 82 (6): 1661-1667.
16. Seidell JC, Björntorp P, Sjöström L, Kvist H, Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism. Sep 1990; 39 (9): 897-901.
17. Khaw KT, Barrett-Connor E. Lower endogenous androgens predict central adiposity in men. Ann Epidemiol. Sep 1992; 2 (5): 675-682.
18. Després JP, Couillard C, Gagnon J, et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol. Aug 2000; 20 (8): 1932-1938.
19. Tchernof A, Labrie F, Bélanger A, et al. Relationships between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variables. Atherosclerosis. Sep 1997; 133 (2): 235-244.
19. Reid IR, Wattie DJ, Evans MC, Stapleton JP. Testosterone therapy in glucocorticoid-treated men. Arch Intern Med. Jun 1996; 156 (11): 1173-1177.
20. Amory JK, Watts NB, Easley KA, et al. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab. Feb 2004; 89 (2): 503-510.
21. Crawford BA, Liu PY, Kean MT, Bleasel JF, Handelsman DJ. Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment. J Clin Endocrinol Metab. Jul 2003; 88 (7): 3167-3176.
22. Bilezikian JP. Osteoporosis in men. J Clin Endocrinol Metab. Oct 1999; 84 (10): 3431-3434.
23. Orwoll ES, Klein RF. Osteoporosis in men. Endocr Rev. Feb 1995; 16 (1): 87-116.
24. Poór G, Atkinson EJ, Lewallen DG, O’Fallon WM, Melton LJ. Age-related hip fractures in men: clinical spectrum and short-term outcomes. Osteoporos Int. 1995; 5 (6): 419-426.

Related Article(s)
  1. FDA Approved HGH Products

    FDA Approved HGH Products The following table lists all FDA approved growth hormone products. If you and your physician pursue...

  2. Testosterone Replacement Therapy (TRT) and the Heart

    Testosterone Replacement Therapy (TRT) and the Heart The Misconception Historically, a major concern about testosterone replacement therapy was that it...

  3. Is HGH Legal?

    Is HGH Legal? The laws concerning the use of human growth hormone are confusing as they differ from state to...